GuidelineJournal of the American College of Cardiology2014
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Erratum issued 10 registry-linked trialsAbstract readPractice Guideline
In one paragraph
Guideline in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 10 registered trials, which are not on this map. Cited by 1,829 papers, 6 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,829citing papers in PubMed, 6 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
Open the trial in the graphEffects of the PCSK9 Antibody AliroCuMab on Coronary Atherosclerosis in PatieNts With Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy And Optical Coherence Tomography Imaging Study
PMID 25687353PMID 25773378PMID 24631113PMID 22019821PMID 22421222PMID 22421299PMID 23871513PMID 30336824PMID 27846344PMID 26655874PMID 26330422PMID 25182248other papers from this trial
Open the trial in the graphEstudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina
PMID 27046161PMID 25537708PMID 24793440PMID 24793441PMID 24793443PMID 16034009PMID 26939026PMID 17039901PMID 23190071PMID 19604523PMID 25915661PMID 19618992other papers from this trial
Open the trial in the graphComparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus in Prediabetic Patients With Atherosclerotic Cardiovascular Disease
PMID 29263150PMID 23704171PMID 21693744PMID 20167359PMID 29718253PMID 30586774PMID 29165385PMID 28886621PMID 22410123PMID 17601626PMID 17559928PMID 12186811other papers from this trial
Open the trial in the graphRandomized Controlled Clinical Trial for Assessing Tolerability and Effectiveness of Formula Coleosoma 29 in Patients With Dyslipidemia
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. A Randomized, Double Blind, Placebo-controlled Clinical Trial.
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
Prospective Electronic Polygenic Risk Study (PEPRS) - First Phase
Prospective Electronic Polygenic Risk Study - Second Phase
Tracking Lipid-Lowering Therapy Over One Year in Middle Eastern Patients With ASCVD. The Jordan LLA Tracking Study
Who cites it
1,829 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- [Practical guideline on the prevention and management of diabetic foot in China (Ⅰ)].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2025Guideline
- Does Medication Status Impact the Effectiveness of Nuts in Altering Blood Pressure and Lipids? A Systematic Review and Meta-Analysis.Nutrition reviews · 2025Pooled it
- The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials.Nutrition journal · 2025Pooled it
- Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials.Current drug targets · 2025Pooled it
- Zinc Supplementation in Individuals with Prediabetes and type 2 Diabetes: a GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.Biological trace element research · 2024Pooled it
- Tracking of apolipoprotein B levels measured in childhood and adolescence: systematic review and meta-analysis.European journal of pediatrics · 2024Pooled it
- Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.Journal of clinical hypertension (Greenwich, Conn.) · 2024Trial
- Article
- Plasma CAF22, a Biomarker of Neuromuscular Junction Integrity, is Associated with Risk and Earlier Onset of Statin-Associated Muscle Symptoms.Cardiovascular drugs and therapy · 2026Article
- Treat-to-target strategies for low-density lipoprotein cholesterol and triglyceride levels for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia.The Cochrane database of systematic reviews · 2026Article
- The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Cardiovascular Disease Incidence and Lipid-Lowering Medication Use in Korean Adults With Dyslipidemia: A Nationwide Population-Based Retrospective Cohort Study From 2010 to 2019.Journal of lipid and atherosclerosis · 2026Article
- Severe Hypercholesterolemia Caused by Mesalazine Which Is a Key Drug of Ulcerative Colitis.Internal medicine (Tokyo, Japan) · 2026Article
- Effect of dolutegravir on 'Life's Simple 7' cardiovascular risk factors: A longitudinal analysis from Tanzania.HIV medicine · 2026Article
- Interferon Regulatory Factors as Potential Therapeutic Targets in Cardiovascular Disease: Focusing on Vascular Inflammation.International journal of molecular sciences · 2026Review
- Association of medical visit frequency with cardiovascular events and mortality in patients with dyslipidaemia: a cohort study using a Japanese claims database.Journal of health, population, and nutrition · 2026Article
- Joint association of LDL cholesterol and inflammation with mortality and the modifying effect of physical activity: findings from two population-based cohort studies.Lipids in health and disease · 2026Article
- Unmasking the role of hypertension in atherosclerosis among patients with obesity: a cardiometabolic dysfunction perspective.International journal of obesity (2005) · 2026Observational
- Association of cholesterol, high-density lipoprotein, and glucose index and modified indices in predicting cardiovascular diseases incidence among population with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.BMC cardiovascular disorders · 2026Article
- Association of long-term exposure to lower low-density lipoprotein cholesterol with neuroimaging metrics: A population-based cohort study.Chinese medical journal · 2026Observational
1,769 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Erratum issued
- Erratum issued
Authors and funding
17 authors.
Neil J Stone
Jennifer G Robinson
Alice H Lichtenstein
C Noel Bairey Merz
Conrad B Blum
Robert H Eckel
Anne C Goldberg
David Gordon
Daniel Levy
Donald M Lloyd-Jones
Patrick McBride
J Sanford Schwartz
Susan T Shero
Sidney C Smith
Karol Watson
Peter W F Wilson
American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAmerican Heart AssociationCardiologyCholesterol, HDLCholesterol, LDLCoronary Artery DiseaseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaRisk AssessmentRisk FactorsRisk Reduction BehaviorSocieties, MedicalUnited StatesCholesterol, HDLCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsACC/AHA Practice Guidelinebiomarkers, pharmacologicalcardiovascular diseasecholesteroldiabetes mellitusdrug therapyhydroxymethylglutaryl-CoA reductase inhibitors/statinshypercholesterolemialipidspatient complianceprimary preventionrisk assessmentrisk reduction behaviorsecondary prevention
Identifiers
PMID
24239923What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT02740699ClinicalTrials.gov
NCT03067844ClinicalTrials.gov
NCT03696940ClinicalTrials.gov
NCT06767774ClinicalTrials.gov
NCT03027336ClinicalTrials.gov
NCT03216057ClinicalTrials.gov
and 4 more above
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.